Received Feb 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 25ZH4 | — |
administered a dose of Kinrix which was expired on 27th Oct, 2024; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 5-year-old male patient who received DTPa-IPV (Kinrix) (batch number 25ZH4, expiry date 27-OCT-2024) for prophylaxis. On 14-JAN-2025, the patient received Kinrix. On 14-JAN-2025, an unknown time after receiving Kinrix, the patient experienced expired vaccine used (Verbatim: administered a dose of Kinrix which was expired on 27th Oct, 2024). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 14-JAN-2025 Other HCP reported that administered a dose of Kinrix to a 5 year old male patient on 14th Jan, 2025 which had an expiration date of 27th Oct, 2024, which led to expired product used. The vaccines were quarantined in the back of the fridge but apparently the staff member did not notice the sign. At the time of reporting, a repeat dose has not been administered.